ReP USP - Resultado da busca

Filtros : "Scrideli, Carlos Alberto" "FFCLRP-592" "2011" Removidos: "LINFÓCITOS" "FORP-803" "Federação de Sociedades de Biologia Experimental" Limpar

Filtros

USP affiliated authors
- hojo, elza tiemi sakamoto (~2)
- scrideli, carlos alberto (~2)
- tone, luiz gonzaga (~2)
- morales, andressa gois (~1)
Date published
- 2011 (~2)
Subjects
- citogenética (1)
- crianças (1)
- fármacos (1)
- leucemia (1)
- mitose (1)

Artigo de periodico
Cytogenetic instability in childhood acute lymphoblastic leukemia survivors (2011)
Brassesco, María Sol; Xavier, Danilo Jordão; Camparoto, Marjori Leiva; Montaldi, Ana Paula; Godoy, Paulo Roberto D'Auria Vieira de; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Sakamoto-Hojo, Elza Tiemi
Source: Journal of Biomedicine and Biotechnology. Unidades: FMRP, FFCLRP
Subjects: CRIANÇAS, LEUCEMIA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María Sol et al. Cytogenetic instability in childhood acute lymphoblastic leukemia survivors. Journal of Biomedicine and Biotechnology, v. 2011, 2011Tradução . . Acesso em: 06 nov. 2024.
APA
Brassesco, M. S., Xavier, D. J., Camparoto, M. L., Montaldi, A. P., Godoy, P. R. D. 'A. V. de, Scrideli, C. A., et al. (2011). Cytogenetic instability in childhood acute lymphoblastic leukemia survivors. Journal of Biomedicine and Biotechnology, 2011.
NLM
Brassesco MS, Xavier DJ, Camparoto ML, Montaldi AP, Godoy PRD'AV de, Scrideli CA, Tone LG, Sakamoto-Hojo ET. Cytogenetic instability in childhood acute lymphoblastic leukemia survivors. Journal of Biomedicine and Biotechnology. 2011 ;2011[citado 2024 nov. 06 ]
Vancouver
Brassesco MS, Xavier DJ, Camparoto ML, Montaldi AP, Godoy PRD'AV de, Scrideli CA, Tone LG, Sakamoto-Hojo ET. Cytogenetic instability in childhood acute lymphoblastic leukemia survivors. Journal of Biomedicine and Biotechnology. 2011 ;2011[citado 2024 nov. 06 ]
Artigo de periodico
BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity (2011)
Morales, Andressa Gois; Brassesco, Maria Sol; Pezuk, Julia Alejandra; Oliveira, Jaqueline Carvalho de; Montaldi, Ana Paula; Hojo, Elza Tiemi Sakamoto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Anti-Cancer Drugs. Unidades: IB, FFCLRP, FMRP
Subjects: OSTEOSSARCOMA (TRATAMENTO), FÁRMACOS, MITOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORALES, Andressa Gois et al. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, v. 22, n. 10, p. 995-1001, 2011Tradução . . Disponível em: https://doi.org/10.1097/cad.0b013e32834a16d4. Acesso em: 06 nov. 2024.
APA
Morales, A. G., Brassesco, M. S., Pezuk, J. A., Oliveira, J. C. de, Montaldi, A. P., Hojo, E. T. S., et al. (2011). BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, 22( 10), 995-1001. doi:10.1097/cad.0b013e32834a16d4
NLM
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4
Vancouver
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024